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Plant molecular breeding represents a new technology that adds to, rather 
than substitutes for, traditional breeding practice, and shares with it the same 
long-standing objectives: higher yield, better producís, better-adapted plants. 
Additionally, it allows the consideration of completely new applications: 
pharmaceuticals, industrial producís and bioremediation processes. Safety 
issues and the socio-economic prospects of this new technology are 
discussed. 
Novel versus traditional technologies 
Crop species ceased to be 'natural' - that is, lost their ability to survive by 
themselves in Nature - in the process of acquiring their main agronomic traits. 
Modern molecular techniques are clarifying how drastic were the genetic changes 
introduced during domestication, as well as during the slow breeding process that 
took place in subsequent centuries. Genetic engineering methods are now being 
extensively applied to the improvement of crop plants; however, the new 
technology will not replace the well-established plant breeding methods that have 
been developed over the past ten millennia. 
Plant genomes, which contain 25 000-30 000 genes, have undergone numerous 
changes in the course of the improvement of both multigenic and oligogenic 
agronomic traits. Classical breeding techniques are still the most effective 
approach when dealing with traits controlled by múltiple genes distributed over 
the genome, especially with the aid of molecular markers, whereas genetic 
engineering is to be preferred in the manipulation of traits that depend on one or 
a few genes. Novel methods add a new dimensión to traditional plant breeding 
practice with respect to its long-term objectives, such as yield and quality 
improvement. Additionally, recombinant DNA technology is opening the way to 
entirely new objectives that were previously out of reach. 
Current agricultural challenges 
Since middle of the 20th century, the attainment of higher yields and the 
development of cleaner farming practices have been the two main challenges of 
agriculture. Owing to demographic growth and a rate of soil decay that is difficult 
to compénsate by new soil development, available soil per capita has steadily 
decreased in the past decades, from around 0.5 hectares to half that figure at 
present. In the next 20 years it will be further reduced to 1000-1500 square metres 
per capita. So it must be concluded that, at a global scale, there is no option but 
to increase yield (Tm/ha) of all the main crops. This objective has a special 
significance in relation to biodiversity because, by increasing yields, it will be 
possible to avoid further invasión of natural habitats. 
Agricultural practice has been extremely deleterious to the environment since 
its invention, ten millennia ago, to the present time. This negative impact has 
increased concomitantly with the growth of world population. Although the 
production of a ton of food with a modern cultivar of wheat or corn requires less 
soil, less energy and smaller amounts of fertilizers and phyto-chemicals than did 
similar food under cultivation 30 years ago, the doubling of the world population 
during this period has more than offset the technological progress. The negative 
impact of agricultural production has reached an intolerable magnitude, both to 
the environment, in general, and to biodiversity, in particular. 
Yields of the staple grain crops have been steadily increasing over the past 
decades but, in recent years, this trend is clearly levelling out. Even if we 
extrapólate to the next 30 years the successful increases of the past, the projection 
shows grain déficits in all áreas of the world with the exception of Europe and 
the North-American continent.1 
Oíd and novel objectives _. 
Traditional plant breeding objectives have included the modification of traits that 
are directly related to increased yield, as well as with the improvement of quality 
and other traits that are of interest in the context of sectorial demands. Most of 
the transgenic crop plants that have been approved for cultivation so far do address 
the above-stated challenges of higher-yielding, cleaner agriculture. In effect, pest 
and disease resistant cultivars have the potential to increase yields, by reducing 
losses, and to allow for cleaner agricultural practice, by reducing the requirement 
for phyto-chemicals. For example, insect resistance in half of the cotton cultivated 
in Spain would reduce pesticide use by almost 1000 tons. Other applications also 
have the potential to reduce environmental impacts. Thus, herbicide-resistant 
cultivars allow minimum-tillage, a practice that drastically reduces erosión and 
is clearly beneficial to the biodiversity of soil biota in the farming plot. In addition, 
according to a survey carried out by the American Soybean Association, the 
change to herbicide-resistant plants and to reduced-tillage practices for this crop 
in the US has led to an estimated reduction in energy consumption that represents 
886 million litres of fuel per year. Whether or not each transgenic application 
fulfils specific expectations requires a case-by-case discussion. 
Of course, a number of innovations do not respond to the main agricultural 
challenges and address sectorial demands, from alterations of post-harvest 
properties for food processing, such as delayed-ripening tomatoes, to those that 
meet certain nutritive requirements, as is the case of a rice cultivar with enhanced 
contení of provitamin A and iron. 
Often overlooked is the fact that the new techniques allow the engineering of 
transgenic plants whose solé purpose is to serve in the screening of a new 
generation of phyto-chemicals with environment-compatible properties, i.e. 
higher specific activity (from kg/ha to g/ha), greater selectivity (so that they ideally 
affect only the organisms to be controlled) and higher biodegradability (so that 
they do not accumulate in the environment). 
Besides converging with classical methods in solving long-standing problems, 
genetic engineering has the potential to introduce completely new properties into 
cultivated plants. These innovations include plants that produce molecules 
of pharmaceutical interest, such as vaccines or peptide hormones, or of 
industrial interest, such as new oils or biodegradable plastics, and plants that 
are more effective in the remediation of contaminated soils or as pollution 
monitor s. 
The relevance of each application will have to be judged on the basis of its 
individual merits. Transgenic technology is here to stay. Over 45 million ha of 
transgenic crops are already cultivated in more than a dozen countries. There 
should not be any doubt that, generically speaking, this technology offers great 
promise as an ingredient for possible solutions to the problem of how to conciliate 
the production of food for an increasing population with the goal of conserving 
the environment and promoting biodiversity. 
Safety issues 
General considerations 
As with any other technology, there is no simple general assessment concerning 
the safety of genetic engineering.2"6 This issue has to be treated on a case-by-case 
basis as, indeed, transgenic crops are approved for commercial use through an 
\ 
application-by-application procedure. Zero risk is a myth, an ideal that is not met 
by any human endeavour. As a negative scientific proposition it is not even 
susceptible of being tested experimentally. 
Each proposal of transgenic application has to be evaluated on the basis of 
benefits-versus-risk and risk-versus-risk considerations. The implementation of 
an approved innovation can be closely monitored, so that the approval can be 
cancelled if the expectations derived from the initial assessment are off target. 
The concept of substantial equivalence, which implies a direct comparison of 
the proposed innovation with that currently in use, offers a rational approach to 
the problem. Both intended and unintended effects should be investigated and 
assessed. Intended effects can be generally evaluated by well-established standard 
protocols whose application is not restricted to transgenic producís. Additionally, 
new tools, high throughput genomic, proteomic and metabolomic methods have 
been developed that allow the investigation of unintended effects, both predictable 
and unpredictable, of genetic alterations, independently of the method used to 
achieve these alterations - classical breeding or genetic engineering. Indeed, risk 
issues are not conceptually different for traditionally bred or for genetically 
engineered cultivars. 
Safety for humans 
Safety considerations concerning the possible effects of transgenic producís on 
humans should address possible toxic effects and potential allergenic problems. 
Standard chronic toxicity tests can be performed with the transgenic material, 
using the isogenic non-transgenic material as a control. Additionally, the toxicity 
of new products differentially present in the transgenic line, whether intended or 
unintended, can be individually assessed if required. Precedents in the literature 
are of great help in this type of assessment. 
Allergy problems affect an increasing number of urban dwellers for reasons that 
are not well known. A considerable number of items from our daily life - from 
rubber gloves to peanuts - can cause allergic reactions in sensitive individuáis. 
Molecules (allergens) and parts of them (epitopes) responsible for this 
phenomenon have been identified in many cases, a circumstance that facilitates 
their analytical monitoring in all kinds of materials, while in other cases, only the 
overall allergenicity of a particular material is known. Under the current legal 
framework, no gene encoding a known allergen may be expressed transgenically 
for commercial use and no gene from a particularly allergenic species may be 
transferred, unless there is evidence that the gene product is not responsible for 
the observed allergy. On the other hand, the potential use of transgenic technology 
to eliminate allergens in plants is frequently overlooked. 
Gene fluxes 
Once a gene has been transferred to a particular species, it becomes an integral 
part of its genetic make-up and will have the same fate as the remaining thousands 
of genes that are part of its genome. Inter-specific genetic fluxes occur in nature 
to a very limited extent and are subject to barriers that are breached with a different 
probability in each case. A pollen grain must fly a certain distance, find an 
appropriate, mature recipient, pollinate, yield a viable seed, capable of developing 
into a non-sterile mature plant and, finally, the progeny of this plant must be viable. 
For certain transformation events, accidental gene transfer to other species is 
highly unlikely, whereas for others there is a certain probability of occurrence. 
These cases are susceptible to experimental evaluation. There is no danger of the 
transfer of plant genes into the genomes of humans or other animáis. After all, 
humans and other animal species have daily consumed thousands of different such 
genes and no evidence has been found in animal genomes of this type of horizontal 
transfer. Also unlikely is that trans-genes will modify gut micro-flora, as there is 
no precedent in the literature of such an event and no evidence of it has been found 
in specific experiments. Nevertheless, European regulations cali for phasing out 
antibiotic resistance genes in transgenic plants. 
The transfer of genes from the cultivated species to related wild species in the 
same habitat occurs with a probability that is different for each species/habitat 
combination. Whether the species is self-fertilized or cross-fertilised, and whether 
or not there are closely related wild species in the vicinity of the cultivated one, 
determine the relevance of this issue in the approval procedure. Thus, maize is 
quite unproblematic from this point of view, whereas alfalfa would have to be 
more closely watched, and cañóla would represent an intermedíate case. Several 
million hectares of transgenic cañóla are currently cultivated in the North-Amer-
ican continent, after an initial approval, and the whole operation is under cióse 
monitoring. The results of these observations will be decisive with respect to the 
future of this transgenic crop. 
Of course, gene transfer to non-transgenic cultivars of the same species only 
requires appropriate synchrony and is limited by distance. This transfer is neither 
a health risk ñor an environmental problem, but it is a commercial requirement. 
It is managed by planting a number of rows of non-transgenic material around 
the transgenic field, by keeping regulation distances between transgenic and 
non-transgenic plots and by monitoring adventitious events by highly sensitive 
analytical methods. 
Environmental safety 
In addition to the above-discussed problems posed by possible gene fluxes, the 
environmental safety of transgenic crops involves two main aspects that, although 
also relevant for classically bred cultivars, require special evaluation in genetically 
engineered crops. These are the possible effects on non-target organisms and the 
possible induction of resistance in the target organism. There are also other 
specialized issues that affect specific applications that need to be considered case 
by case. 
When genetic resistance to a particular target organism (bacteria, fungi, insects 
and others) is introduced into a given cultivar, possible short and long-term effects 
on non-target organisms have to be evaluated. This evaluation has to consider 
current practice as a control. Thus, the effect of the introduction of BT cotton on 
beneficial insects has to be compared with the effect of the repeated insecticidal 
treatments that are included in the state-of-the-art cultivation of non-transgenic 
cultivars. In this context, transformation events that have been approved so far 
for plant protection seem to be more environmentally friendly than current 
technology. 
Induction of resistance in the target organism is to be expected sooner or later 
in all cases of biological control experimented to date, whether insecticides, 
antibiotics or other agents are involved. This induction can be accelerated by 
malpractice and delayed by proper management. Contrary to popular belief, the 
possible induction of resistance should not prevent the application while it is 
useful. In the case of transgenic plants that are resistant to insects, microbial 
diseases or weeds, the implementation of proper management techniques, such 
as refuges, adequate doses and crop rotation, should be in the interest of all parties 
involved - farmers, authorities and companies. 
Socio-economic and ethical prospects 
As already stated, modern molecular breeding has a great potential in relation to 
the attainment of an agricultural practice that is more productive and 
environmentally friendly. As food demand increases, a more productive 
agriculture should permit a saving of wild habitats. Although safety problems are 
not easy to manage, this technology is susceptible for use under reasonable safety 
rules and is not more dangerous a priori than previous practices. This fact should 
not prevent a cióse scrutiny of the new methods because of their novelty. 
Excessive consideration of the potential risks to human health and the 
environment should not blind us to the real socio-economic issues raised by the 
new technology.4'7'8 As it has been developed to a significant extent by prívate 
capital or by public research funds aimed at supporting industrial activity, 
intellectual property protection (patents and others) has been at the forefront of 
discussions concerning this biological revolution. Patents are no doubt necessary 
ingredients of progress. They are the most transparent system of protecting 
research investment, as the main alternative is industrial secrecy. However, the 
concentration in a few hands of most of the relevant intellectual property 
concerning a particular crop should be vigorously avoided. 
A related socio-economic issue of great relevance also stems from the prívate 
nature of this technological innovation, in contrast with the genetic improvements 
achieved during the second half of the 20th century. While it is normal that 
companies should seek to profit out of their investments, this fact may exelude 
developing countries from the benefits of the new technology, despite its great 
potential in the solution of problems that are common to all types of countries and, 
more importantly, to the solution of problems that are specific to the more needy 
sectors of humanity. Thus, it is imperative that new mechanisms and rules should 
be considered to solve this question. 
Apart from the ethical implications of those issues related to the possible 
benefits for developing countries, only general ethical principies - no different 
from those relevant to other industries, such as the automotive or the firearm 
technologies - are involved. 
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